Cargando…

Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019

Background: Drug induced liver injury (DILI) is an adverse drug reaction that causes liver damage in a predictable (dose-dependent) or an unpredictable (idiosyncratic) fashion. We performed an assessment of DILI in Portugal, by analyzing the reports, sent to the Portuguese Pharmacovigilance System (...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes, David Ricardo da Conceição Marçal Alves, Breton, Michèle Claire, Monteiro, Cristina Sofia de Jesus, dos Santos, Jorge Luiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702164/
https://www.ncbi.nlm.nih.gov/pubmed/34946356
http://dx.doi.org/10.3390/healthcare9121630
_version_ 1784621181117136896
author Nunes, David Ricardo da Conceição Marçal Alves
Breton, Michèle Claire
Monteiro, Cristina Sofia de Jesus
dos Santos, Jorge Luiz
author_facet Nunes, David Ricardo da Conceição Marçal Alves
Breton, Michèle Claire
Monteiro, Cristina Sofia de Jesus
dos Santos, Jorge Luiz
author_sort Nunes, David Ricardo da Conceição Marçal Alves
collection PubMed
description Background: Drug induced liver injury (DILI) is an adverse drug reaction that causes liver damage in a predictable (dose-dependent) or an unpredictable (idiosyncratic) fashion. We performed an assessment of DILI in Portugal, by analyzing the reports, sent to the Portuguese Pharmacovigilance System (PPS). Methods: A search was performed on the PPS database, in a 10-year time frame, from 1 January 2010 to 31 December 2019. Results: There was not a prevalence of either sex in any age group. Most reports (n = 1120, 55.0%) belonged to patients in the age group 19–64 years old. Hepatitis (n = 626, 26.7%) was the most common adverse drug reaction in our study. Hepatotoxicity (n = 362, 15.5%) and hepatitis (n = 333, 14.2%) were more frequent in age group 19–64 years old. Cholestasis was more prevalent in adults independently of age. Hepatic fibrosis and encephalopathy were more common in the elderly. Most patients consumed between one and four suspected drugs (n = 1867, 92%). Most patients in our study evolved to “cure” (n = 796; 39%). Hepatotoxicity (n = 23; 13.8%) and hepatitis (n = 610; 25.9%) had a female predominancy while choluria (n = 8; 4.8%) and splenomegaly (n = 8; 4.8%) were of male predominance. Conclusions: DILI is rare but can be fatal. As such, an active search of DILI is necessary.
format Online
Article
Text
id pubmed-8702164
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87021642021-12-24 Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019 Nunes, David Ricardo da Conceição Marçal Alves Breton, Michèle Claire Monteiro, Cristina Sofia de Jesus dos Santos, Jorge Luiz Healthcare (Basel) Article Background: Drug induced liver injury (DILI) is an adverse drug reaction that causes liver damage in a predictable (dose-dependent) or an unpredictable (idiosyncratic) fashion. We performed an assessment of DILI in Portugal, by analyzing the reports, sent to the Portuguese Pharmacovigilance System (PPS). Methods: A search was performed on the PPS database, in a 10-year time frame, from 1 January 2010 to 31 December 2019. Results: There was not a prevalence of either sex in any age group. Most reports (n = 1120, 55.0%) belonged to patients in the age group 19–64 years old. Hepatitis (n = 626, 26.7%) was the most common adverse drug reaction in our study. Hepatotoxicity (n = 362, 15.5%) and hepatitis (n = 333, 14.2%) were more frequent in age group 19–64 years old. Cholestasis was more prevalent in adults independently of age. Hepatic fibrosis and encephalopathy were more common in the elderly. Most patients consumed between one and four suspected drugs (n = 1867, 92%). Most patients in our study evolved to “cure” (n = 796; 39%). Hepatotoxicity (n = 23; 13.8%) and hepatitis (n = 610; 25.9%) had a female predominancy while choluria (n = 8; 4.8%) and splenomegaly (n = 8; 4.8%) were of male predominance. Conclusions: DILI is rare but can be fatal. As such, an active search of DILI is necessary. MDPI 2021-11-25 /pmc/articles/PMC8702164/ /pubmed/34946356 http://dx.doi.org/10.3390/healthcare9121630 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nunes, David Ricardo da Conceição Marçal Alves
Breton, Michèle Claire
Monteiro, Cristina Sofia de Jesus
dos Santos, Jorge Luiz
Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019
title Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019
title_full Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019
title_fullStr Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019
title_full_unstemmed Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019
title_short Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019
title_sort drug induced liver injury: perspective of the adverse drug reaction reports to the portuguese pharmacovigilance system from 2010 to 2019
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702164/
https://www.ncbi.nlm.nih.gov/pubmed/34946356
http://dx.doi.org/10.3390/healthcare9121630
work_keys_str_mv AT nunesdavidricardodaconceicaomarcalalves druginducedliverinjuryperspectiveoftheadversedrugreactionreportstotheportuguesepharmacovigilancesystemfrom2010to2019
AT bretonmicheleclaire druginducedliverinjuryperspectiveoftheadversedrugreactionreportstotheportuguesepharmacovigilancesystemfrom2010to2019
AT monteirocristinasofiadejesus druginducedliverinjuryperspectiveoftheadversedrugreactionreportstotheportuguesepharmacovigilancesystemfrom2010to2019
AT dossantosjorgeluiz druginducedliverinjuryperspectiveoftheadversedrugreactionreportstotheportuguesepharmacovigilancesystemfrom2010to2019